Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Icu Medical (ICUI) Change in Accured Expenses (2016 - 2025)

Icu Medical (ICUI) has disclosed Change in Accured Expenses for 17 consecutive years, with -$8.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Accured Expenses fell 4491.3% year-over-year to -$8.1 million, compared with a TTM value of -$37.0 million through Dec 2025, down 278.86%, and an annual FY2025 reading of -$37.0 million, down 278.86% over the prior year.
  • Change in Accured Expenses was -$8.1 million for Q4 2025 at Icu Medical, up from -$9.1 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $36.7 million in Q2 2024 and bottomed at -$36.3 million in Q1 2025.
  • Average Change in Accured Expenses over 5 years is -$4.0 million, with a median of -$6.3 million recorded in 2022.
  • The sharpest move saw Change in Accured Expenses skyrocketed 269.59% in 2021, then plummeted 4491.3% in 2025.
  • Year by year, Change in Accured Expenses stood at $14.6 million in 2021, then tumbled by 221.87% to -$17.8 million in 2022, then surged by 77.78% to -$3.9 million in 2023, then skyrocketed by 104.66% to $184000.0 in 2024, then tumbled by 4491.3% to -$8.1 million in 2025.
  • Business Quant data shows Change in Accured Expenses for ICUI at -$8.1 million in Q4 2025, -$9.1 million in Q3 2025, and $16.5 million in Q2 2025.